Progression of coronary calcium and near-term risk of myocardial infarction in patients receiving cholesterol-lowering therapy with statins

被引：0
|
作者：
Raggi, P
Callister, T
Shaw, L
机构：
[1] EBT Res Fdn, Nashville, TN USA
[2] Atlanta Cardiovasc Res Inst, Atlanta, GA USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2003年 / 4卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(03)90099-7
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [41] Remnant cholesterol and risk of myocardial infarction in patients with coronary artery disease undergoing revascularization
    Zafrir, Barak
    Khoury, Razi
    Saliba, Walid
    JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (03) : 332 - 341
  • [42] Intensive lipid lowering therapy on progression of coronary atherosclerosis and stroke in high risk patients
    Corinaldesi, G.
    Corinaldesi, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 596 - 596
  • [43] REMNANT CHOLESTEROL AND RISK OF MYOCARDIAL INFARCTION IN PATIENTS WITH CORONARY ARTERY DISEASE UNDERGOING REVASCULARIZATION
    Zafrir, B.
    Khoury, R.
    Saliba, W.
    ATHEROSCLEROSIS, 2023, 379 : S95 - S96
  • [44] Lipid lowering therapy consistently slowed progression of coronary atherosclerosis in subgroups of patients with normal cholesterol levels
    Burton, JR
    Tymchak, W
    Dzavik, V
    Taylor, D
    Catellier, D
    Buller, CE
    Plante, S
    Montague, TJ
    Teo, K
    EUROPEAN HEART JOURNAL, 2000, 21 : 158 - 158
  • [45] Marked Aortic Valve Stenosis Progression After Receiving Long-Term Aggressive Cholesterol-Lowering Therapy Using Low-Density Lipoprotein Apheresis in a Patient With Familial Hypercholesterolemia
    Tsuchida, Masayuki
    Kawashiri, Masa-aki
    Tada, Hayato
    Takata, Mutsuko
    Nohara, Atsushi
    Ino, Hidekazu
    Inazu, Akihiro
    Kobayashi, Junji
    Koizumi, Junji
    Mabuchi, Hiroshi
    Yamagishi, Masakazu
    CIRCULATION JOURNAL, 2009, 73 (05) : 963 - 966
  • [46] Coronary Calcium Is Elevated in Patients with Myocardial Infarction without Standard Modifiable Risk Factors
    Anderson, Jeffrey L.
    Knight, Stacey
    Dong, Li
    May, Heidi T.
    Le, Viet T.
    Bair, Tami L.
    Knowlton, Kirk U.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [47] Lipid-lowering therapy and cholesterol levels following acute myocardial infarction:: A German study of 5361 patients
    Bergmann, A
    Schulze, J
    Hübner, D
    Weizel, A
    Julius, U
    Kreuzer, J
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2003, 18 (05) : 407 - 411
  • [48] When to start cholesterol-lowering therapy in patients with coronary heart disease - A statement for healthcare professionals from the American heart association task force on risk reduction
    Grundy, SM
    Balady, GJ
    Criqui, MH
    Fletcher, G
    Greenland, P
    Hiratzka, LF
    HoustonMiller, N
    KrisEtherton, P
    Krumholz, HM
    LaRosa, J
    Ockene, IS
    Pearson, TA
    Reed, J
    Smith, SC
    Washington, R
    CIRCULATION, 1997, 95 (06) : 1683 - 1685
  • [49] Lipid-lowering therapy and cholesterol levels following acute myocardial infarction: A German study of 5361 patients
    A. Bergmann
    J. Schulze
    D. Hübner
    A. Weizel
    U. Julius
    J. Kreuzer
    European Journal of Epidemiology, 2003, 18 : 407 - 411
  • [50] Remnant Cholesterol Predicts Risk of Cardiovascular Events in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries
    Gao, Side
    Xu, Haobo
    Ma, Wenjian
    Yuan, Jiansong
    Yu, Mengyue
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (10):
12345